These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1071 related items for PubMed ID: 15641079

  • 1. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 3. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD.
    Mol Pharmacol; 2005 Jul 01; 68(1):169-78. PubMed ID: 15821150
    [Abstract] [Full Text] [Related]

  • 4. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar 01; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 5. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun 01; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.
    Sabichi AL, Subbarayan V, Llansa N, Lippman SM, Menter DG.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov 01; 13(11 Pt 1):1704-9. PubMed ID: 15533896
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis.
    Koyama M, Izutani Y, Goda AE, Matsui TA, Horinaka M, Tomosugi M, Fujiwara J, Nakamura Y, Wakada M, Yogosawa S, Sowa Y, Sakai T.
    Clin Cancer Res; 2010 Apr 15; 16(8):2320-32. PubMed ID: 20371690
    [Abstract] [Full Text] [Related]

  • 8. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
    Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D.
    Mol Pharmacol; 2004 Nov 15; 66(5):1349-58. PubMed ID: 15317873
    [Abstract] [Full Text] [Related]

  • 9. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW.
    Life Sci; 2009 Jul 03; 85(1-2):46-53. PubMed ID: 19409914
    [Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
    Fahmi H, Di Battista JA, Pelletier JP, Mineau F, Ranger P, Martel-Pelletier J.
    Arthritis Rheum; 2001 Mar 03; 44(3):595-607. PubMed ID: 11263774
    [Abstract] [Full Text] [Related]

  • 11. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T, Faour WH, He QW, Fahmi H, Martel-Pelletier J, Pelletier JP, Di Battista JA.
    Arthritis Rheum; 2002 Feb 03; 46(2):494-506. PubMed ID: 11840453
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.
    Rheumatology (Oxford); 2005 Aug 03; 44(8):983-8. PubMed ID: 15840591
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells.
    Bamba H, Ota S, Kato A, Kawamoto C, Fujiwara K.
    Biochem Biophys Res Commun; 2000 Jul 05; 273(2):485-91. PubMed ID: 10873632
    [Abstract] [Full Text] [Related]

  • 14. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.
    Yokoyama Y, Masaki T, Kiribayashi K, Nakashima A, Kokoroishi K, Ogawa T, Kohno N, Yorioka N.
    Ther Apher Dial; 2010 Feb 05; 14(1):43-51. PubMed ID: 20438519
    [Abstract] [Full Text] [Related]

  • 15. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
    Kang J, Chen J, Shi Y, Jia J, Zhang Y.
    Biochem Pharmacol; 2005 Apr 15; 69(8):1205-13. PubMed ID: 15794941
    [Abstract] [Full Text] [Related]

  • 16. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S, Inoue H, Flowers LC, Sidell N.
    Clin Cancer Res; 2003 Oct 01; 9(12):4627-35. PubMed ID: 14555539
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
    Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M.
    Mol Pharmacol; 2007 Nov 01; 72(5):1246-57. PubMed ID: 17673570
    [Abstract] [Full Text] [Related]

  • 18. 15-Deoxy-Delta(12,14)-prostaglandin J(2) impairs the functions of histone acetyltransferases through their insolubilization in cells.
    Hironaka A, Morisugi T, Kawakami T, Miyagi I, Tanaka Y.
    Biochem Biophys Res Commun; 2009 Dec 11; 390(2):290-4. PubMed ID: 19799872
    [Abstract] [Full Text] [Related]

  • 19. Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes.
    Min SY, Hwang SY, Jung YO, Jeong J, Park SH, Cho CS, Kim HY, Kim WU.
    J Rheumatol; 2004 May 11; 31(5):875-83. PubMed ID: 15124245
    [Abstract] [Full Text] [Related]

  • 20. Basic calcium phosphate crystal-induced prostaglandin E2 production in human fibroblasts: role of cyclooxygenase 1, cyclooxygenase 2, and interleukin-1beta.
    Morgan MP, Whelan LC, Sallis JD, McCarthy CJ, Fitzgerald DJ, McCarthy GM.
    Arthritis Rheum; 2004 May 11; 50(5):1642-9. PubMed ID: 15146435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.